Search Within

Population Sciences Research Program

  1. "Thoracic Oncology"
  2. "Surgery"
  3. "Body Imaging Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Biostatistics Service (7)
  2. Body Imaging Service (7)
  3. Department of Medicine (7)
  4. Epidemiology and Biostatistics (7)
  5. Radiology, Department of (7)
  6. Solid Tumor Oncology Division (7)

More Groups

People
  1. Valerie Rusch (5)
  2. Marjorie Zauderer (4)
  3. Ronglai Shen (4)
  4. Andreas Rimner (3)
  5. Charles Rudin (3)
  6. Gregory Riely (3)

More People

Years
  1. 2022 (1)
  2. 2018 (2)
  3. 2017 (1)
  4. 2016 (2)
  5. 2010 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Clinical Cancer Research (2)
  3. Journal of Thoracic Oncology (1)
  4. Nature Medicine (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (1)
  4. Nature Publishing Group (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant galinpepimut-S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Tsao, A. S.; Dao, T.; Panageas, K.; Lai, W. V.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Ginsberg, M. S.; Gomez, D.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma
    Journal Article

    Rimner, A.; Zauderer, M. G.; Gomez, D. R.; Adusumilli, P. S.; Parhar, P. K.; Wu, A. J.; Woo, K. M.; Shen, R.; Ginsberg, M. S.; Yorke, E. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development
    Journal Article

    Zhao, B.; Oxnard, G. R.; Moskowitz, C. S.; Kris, M. G.; Pao, W.; Guo, P.; Rusch, V.; Ladanyi, M.; Rizvi, N. A.; Schwartz, L. H.
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save